EUVIMEDEUVIMED entdecken
Crossref

Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy

Gohar S Manzar, Molly B El Alam, Erica J Lynn, Tatiana V Karpinets, Timothy Harris, David Lo, Kyoko Yoshida-Court, Tatiana Cisneros Napravnik, Julie Sammouri, Daniel Lin, Lauren M Andring, Julianna Bronk und 12 weitere

Brachytherapy · 2024

DOI: 10.1016/j.brachy.2023.10.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brachytherapy, 2024. Verfasst von Gohar S Manzar und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Brachytherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Institutes of Health, ASCO, The University of Texas MD Anderson Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chemoradiation (CRT) may modulate the immune milieu as an in-situ vaccine. Rapid dose delivery of brachytherapy has unclear impact on T-cell repertoires. HPV-associated cancers express viral oncoproteins E6/E7, which enable tracking antigen/tumor-specific immunity during CRT. METHODS: Thirteen cervical cancer patients on a multi-institutional prospective protocol from 1/2020-1/2023 underwent standard-of-care CRT with pulsed-dose-rate brachytherapy boost (2 fractions). Cervix swabs at various timepoints underwent multiplex DNA deep sequencing of the TCR-β/CDR3 region with immunoSEQ. Separately, HPV-responsive T-cell clones were also expanded ex vivo. Statistical analysis was via Mann-Whitney-U. RESULTS: TCR productive clonality, templates, frequency, or rearrangements increased post-brachytherapy in 8 patients. Seven patients had E6/E7-responsive evolution over CRT with increased productive templates (ranges: 1.2-50.2 fold-increase from baseline), frequency (1.2-1.7), rearrangements (1.2-40.2), and clonality (1.2-15.4). Five patients had HPV-responsive clonal expansion post-brachytherapy, without changes in HPV non-responsive clones. Epitope mapping revealed VDJ rearrangements targeting cervical cancer-associated antigens in 5 patients. The only two patients with disease recurrence lacked response in all metrics. A lack of global TCR remodeling correlated with worse recurrence-free survival, p = 0.04. CONCLUSION: CRT and brachytherapy alters the cervical cancer microenvironment to facilitate the expansion of specific T-cell populations, which may contribute to treatment efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsBrachytherapyFemaleHumansCervix UteriT-LymphocytesProspective StudiesNeoplasm Recurrence, LocalReceptors, Antigen, T-CellTumor Microenvironment

Stichwörter der Autor:innen

Antigen-specific immunityBrachytherapyCervical cancerHPVRadiation therapyT-cell repertoire

Substanzen

Receptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: lcolbert@mdanderson.org.

Förderung

  • National Institutes of Health
  • ASCO
  • The University of Texas MD Anderson Cancer Center

Zitieren

APA

Manzar, G. S., Alam, M. B. E., Lynn, E. J., Karpinets, T. V., Harris, T., Lo, D., Yoshida-Court, K., Napravnik, T. C., Sammouri, J., Lin, D., Andring, L. M., Bronk, J., Wu, X., Sims, T. T., Mathew, G., Schmeler, K. M., Eifel, P. J., Jhingran, A., Lin, L. L., …, & Colbert, L. E. (2024). Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy. Brachytherapy. https://doi.org/10.1016/j.brachy.2023.10.007

Vancouver

Manzar GS, Alam MBE, Lynn EJ, Karpinets TV, Harris T, Lo D, et al. Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy. Brachytherapy. 2024. doi:10.1016/j.brachy.2023.10.007

BibTeX
@article{Manzar2024,
  author = {Manzar, Gohar S and Alam, Molly B El and Lynn, Erica J and Karpinets, Tatiana V and Harris, Timothy and Lo, David and Yoshida-Court, Kyoko and Napravnik, Tatiana Cisneros and Sammouri, Julie and Lin, Daniel and Andring, Lauren M and Bronk, Julianna and Wu, Xiaogang and Sims, Travis T and Mathew, Geena and Schmeler, Kathleen M and Eifel, Patricia J and Jhingran, Anuja and Lin, Lilie L and Joyner, Melissa M and Zhang, Jianhua and Futreal, Andrew and Klopp, Ann H and Colbert, Lauren E},
  title = {Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy},
  journal = {Brachytherapy},
  year = {2024},
  doi = {10.1016/j.brachy.2023.10.007}
}
Kostenlos starten →